Searching in Healthcare & Life Sciences · Search everything
12 changes Notice, last 7 days
Illegal Animal Medicines Seizures, Improvement Notices and Prosecutions
The Veterinary Medicines Directorate (VMD) publishes a rolling 12-month listing of enforcement actions under the Veterinary Medicines Regulations 2013 (VMR), including seizure notices, improvement notices, and prosecutions involving illegal animal medicines. The listing covers activities from August 2024 through April 2026, with updates added as enforcement actions occur. The VMD exercises powers of entry and inspector powers under the VMR to address non-compliance with animal medicine regulations.
Top Ten Imported Veterinary Medicines Quarterly Report Q1 2026
The UK Veterinary Medicines Directorate published its quarterly statistical report on certificates issued under the Special Import System for Q1 2026. Artuvetrin Therapy led with 3,256 certificates (27% of total), followed by Arthramid Vet with 1,346 certificates (11%). The top ten products collectively account for 58% of all certificates issued during the period. This is an informational report with no regulatory obligations or compliance requirements.
VMD Published Standards 2025 to 2026: Monitoring Performance
The UK Veterinary Medicines Directorate (VMD) published its official statistics report monitoring performance against published standards for the period 2025 to 2026 up to 31 March 2026. The report includes monthly performance summaries from September 2025 through March 2026. This is an informational publication providing performance data rather than establishing new regulatory requirements.
Renewed Women's Health Strategy for England
The DHSC has published the Renewed Women's Health Strategy for England, a 10-year plan outlining how the government will improve women's health and healthcare. The strategy aligns with the 10 Year Health Plan for England and aims to ensure women have voice, choice and power in their health and healthcare. The strategy was published on 15 April 2026.
Renewed Women's Health Strategy Published by DHSC and NHS England
DHSC and NHS England have published the renewed Women's Health Strategy, announcing plans to improve women's healthcare experiences across England. Key initiatives include a trial linking women's feedback to provider funding, a single referral point to reduce waiting lists for conditions like endometriosis, and new standards for pain relief during gynaecological procedures. The strategy aims to address systemic issues where women's symptoms have been dismissed or inadequately treated.
MHRA Annual Accountability Review Minutes 2015 to 2025
The Department of Health and Social Care has published transparency data listing MHRA annual accountability review minutes from 2014-15 through 2024-25. The page was updated on 15 April 2026 to add the 2024-25 review minutes from 29 October 2025. No new compliance obligations are created by this administrative listing.
Clinical Trial Setup Time Falls to 122 Days
DHSC announces that average setup time for commercial interventional clinical trials in the UK has fallen to 122 days, down from 169 days for the same period last year. The £137 million investment in health research reforms has streamlined processes and reduced bureaucracy. This progress advances the Prime Minister's commitment to get UK clinical trials up and running within 150 days by March 2026.
Donna Ockenden Appointed Chair of Independent Sussex Maternity Review
The UK Department of Health and Social Care has announced the appointment of Donna Ockenden as Chair of an independent review into Sussex maternity and neonatal services. Ockenden, known for leading the Shrewsbury and Telford NHS Trust review, was confirmed following direct engagement between the Health Secretary and bereaved families who campaigned for an independent review. The review is part of a government initiative to improve maternity safety across the NHS.
Part 2A Health Protection Orders Transparency Data 2017-2025
UKHSA published anonymised transparency data summaries of statutory Part 2A health protection orders for financial years 2017-2018 through 2024-2025. Part 2A orders are statutory instruments used to protect public health through measures such as restricting movement, detaining individuals, and closing premises. The transparency data includes ODS format spreadsheet files for each financial year. No new compliance obligations are created for external parties.
HIV Annual Data 2025: Testing, PrEP, New Diagnoses and Care Outcomes
UKHSA published annual HIV surveillance data for 2025 covering HIV testing, PrEP, PEP, new diagnoses, AIDS, deaths, and care outcomes across England, Wales, Northern Ireland, and Scotland. Data tables include demographic breakdowns, geographic region analysis, and key population statistics from 2015 to 2024. A slide set for presentational use is also available.